Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients

An Exploratory Study of MT-1303 in Subjects With Systemic Lupus Erythematosus (a Multicenter, Open-label Study)

The purpose of this study is to evaluate the safety/tolerability and to explore the efficacy of MT-1303 in subjects with systemic lupus erythematosus

Inclusion Criteria:

• Diagnosis of SLE based on the American College of Rheumatology (ACR) criteria
• Presence of at least one of the following items: positive anti ds-DNA antibodies, low complement levels, and so on.
• Stable doses of corticosteroids

Exclusion Criteria:

• Severe active lupus nephritis, neuropsychiatric SLE